参考文献/References:
[1] GIBSON K S, BRACKNEY K. Periviable premature rupture of membranes[J]. Obstetrics and Gynecology Clinics of North America, 2020, 47(4): 633-651.
[2] BECK C, GALLAGHER K, TAYLOR L A, et al. Chorioamnionitis and risk for maternal and neonatal sepsis: a systematic review and meta-analysis[J].Obstetrics and Gynecology, 2021, 137(6): 1007-1022.
[3] ALJERIAN K. Chorioamnionitis: establishing a correlation between clinical and histological diagnosis[J].Indian Journal of Pathology & Microbiology, 2020,63(1): 44-48.
[4] OH J W, MOON K C, PARK C W, et al. Acute chorioamnionitis and intra-amniotic inflammation are more severe according to outside-in neutrophil migration within the same chorio-decidua[J]. Taiwanese Journal of Obstetrics Gynecology, 2021, 60(4): 639-652.
[5] REN Jie, QIANG Zhe, LI Yuanyuan, et al. Biomarkers for a histological chorioamnionitis diagnosis in pregnant women with or without group B Streptococcus infection: a case-control study[J]. BMC Pregnancy and Childbirth, 2021, 21(1): 250.
[6] RYAN E, EVES D, MENON P J, et al. Histological chorioamnionitis is predicted by early infant C-reactive protein in preterm infants and correlates with neonatal outcomes[J]. Acta Paediatrica, 2020, 109(4): 720-727.
[7] FAN Qingxin, LIU Jiahui, MO Degang. Systemic immune-inflammatory index as a novel biomarker of carotid artery stenosis[J]. Angiology, 2023, 74(8): 798-799.
[8] 曹志文, 宋东奎, 魏晓松, 等. 术前全身免疫炎症指数对非肌层浸润性膀胱癌患者肿瘤复发的预测价值[J]. 天津医药, 2021, 49(2): 159-164. CAO Zhiwen, SONG Dongkui, WEI Xiaosong, et al. The predictive value of preoperative systemic immuneinflammation index for tumor recurrence in patients with non-muscular invasive bladder cancer[J]. Tianjin Medical Journal, 2021, 49(2): 159-164.
[9] VELISSARIS D, ZAREIFOPOULOS N, KARAMOUZOS V, et al. Presepsin as a diagnostic and prognostic biomarker in sepsis[J]. Cureus, 2021, 13(5): e15019.
[10] 谢幸, 苟文丽. 妇产科学[M].8 版. 北京:人民卫生出版社, 2013:133-135. XIE Xing, GOU Wenli. Obstetrics and Gynecology[M].8th Ed. Beijing: People’s Medical Publishing House,2013:133-135.
[11] 吴慧, 韩文龙, 柏蕾, 等. 胎膜早破产妇血清SFRP5,TIMP-1 和HMGB1 水平与并发组织学绒毛膜羊膜炎的相关性研究[J]. 现代检验医学杂志,2022, 37(5): 112-117, 158. WU Hui, HAN Wenlong, BAI Lei, et al. Correlation of serum SFRP5, TIMP-1 and HMGB1 levels with histological chorioamnitis in pregnant women with premature rupture of membranes[J]. Journal of Modern Laboratory Medicine, 2022, 37(5): 112-117, 158.
[12] 尹红亚, 童重新, 何瑞芝, 等. 血清IL-17 及TGF-β细胞因子与未足月胎膜早破并发组织学绒毛膜羊膜炎的关系[J]. 中南医学科学杂志, 2021, 49(1): 63-67. YIN Hongya, TONG Chongxin, HE Ruizhi, et al. Relationship between serum IL-17, TGF-β cytokines and histologic chorioamnionitis in preterm premature rupture of membranes[J]. Medical Science Journal of Central South China, 2021, 49(1): 63-67.
[13] SUNG J H, CHOI S J, OH S Y, et al. Should the diagnostic criteria for suspected clinical chorioamnionitis be changed?[J]. The Journal of Maternal Fetal Neonatal Medicine, 2021, 34(5): 824-833.
[14] 邹小红, 凌利芬, 刘小晴, 等. NLR 和SII 在不同类型血流感染中的诊断价值[J]. 检验医学与临床,2021, 18(17): 2501-2503. ZOU Xiaohong, LING Lifen, LIU Xiaoqing, et al. The value of NLR and SII in the diagnosis of different types of bloodstream infections[J]. Laboratory Medicine and Clinic, 2021, 18(17): 2501-2503.
[15] SHI Haoning, SUN Lingling, WANG Zhenjie, et al. Non-invasive prediction of histologic chorioamnionitis using maternal serum markers in women with preterm prelabour rupture of membranes[J]. American Journal of Reproductive Immunology, 2022, 88(3): e13594.
[16] 郭孝君, 张雪芹, 何远敏, 等. 基于ROC 曲线评价血常规指标中系统性炎症参数识别硬膜外镇痛相关产时发热与组织型绒毛膜羊膜炎的临床价值[J]. 中国实用妇科与产科杂志, 2021, 37(7): 753-756. GUO Xiaojun, ZHANG Xueqin, HE Yuanmin, et al. Evaluating the clinical value of systemic inflammatry indexes in identifying epidural analgesia-related maternal fever and histological chorioamnionitis based on ROC curve[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2021, 37(7): 753-756.
[17] GAD G I, SHINKAR D M, KAMEL EL-DIN M M,et al. The utility of soluble CD14 subtype in early diagnosis of culture-proven early-onset neonatal sepsis and prediction of outcome[J]. American Journal of Perinatology, 2020, 37(5): 497-502.
[18] 郭宇, 刘颖, 梁玉龙, 等. 新型生物标志物Presepsin在临床感染性疾病诊疗中的应用与探讨[J]. 临床检验杂志, 2022, 40(2): 132-137. GUO Yu, LIU Ying, LIANG Yulong, et al. Application and investigation of a novel biomarker Presepsin in the diagnosis and treatment of clinical infectious diseases[J]. Chinese Journal of Clinical Laboratory Science, 2022, 40(2): 132-137.